Abstract P5-10-04: Spectrum of hereditary breast and ovarian cancer gene variants in an African American cohort
Conclusion: This study showed neoadjuvant chemotherapy could increase the BCS success rate but could not decrease the re-excision rate. The re-excision rate is more associated with pathologic finding rather than effect of neoadjuvant chemotherapy.Citation Format: Shah PD, Digiovanni L, Maxwell KN, Bradbury AR, Van Den Akker J, Kim S, Gil E, Simon MS, Nathanson KL, Domchek SM. Spectrum of hereditary breast and ovarian cancer gene variants in an African American cohort [abstract]. In: Proceedings of the Thirty-Ninth Annual CTRC-AACR San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-10-04.
Source: Cancer Research - Category: Cancer & Oncology Authors: PD Shah, L Digiovanni, KN Maxwell, AR Bradbury, J Van Den Akker, S Kim, E Gil, MS Simon, KL Nathanson, SM Domchek Tags: Poster Session Abstracts Source Type: research
More News: Breast Cancer | Breast Conservation Surgery | Cancer | Cancer & Oncology | Chemotherapy | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Genetics | Hormones | Mammography | Mastectomy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Ovarian Cancer | Ovaries | Statistics | Study | Ultrasound | Women